Skip to search formSkip to main contentSkip to account menu

PCSK9 protein, human

Known as: proprotein convertase subtilisin kexin 9, human, Proprotein Convertase Subtilisin/Kexin Type 9, Neural Apoptosis Regulated Convertase 1 
Proprotein convertase subtilisin/kexin type 9 (692 aa, ~74 kDa) is encoded by the human PCSK9 gene. This protein is involved in the degradation of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Lipid-lowering therapy with statins has been established as effective treatment for preventing cardiovascular events. However, a… 
2015
2015
Background: Proprotein convertase subtilisin/kexin 9 (PCSK9) is a protein that prevents low-density lipoprotein (LDL) clearance… 
2014
2014
The second author’s name is incorrect. The correct name is Robin Fortt. The correct citation is: Witney TH, Fortt R, Aboagye EO… 
2013
2013
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Many of the patients with non-small cell lung cancer… 
2012
2012
Background: Replacing SFAs with vegetable PUFAs has cardiometabolic benefits, but the effects on liver fat are unknown. Increased… 
2010
2010
Proprotein convertase subtilisin-like / kexin type 9 (PCSK9) is an emerging target for pharmaceutical intervention. This… 
2009
2009
Objectives : This study aimed to understand the influence of acupuncture on the human body by comparing changes within human… 
2009
2009
Objectives: This study aimed to understand the influence of acupuncture on the human body by comparing changes within human… 
1979
1979
An ultraviolet absorption difference spectrum that is typical of a change in ionization state (pKa 9.7 leads to greater than 11.5…